Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
Clinical trial NCT05384496 · RECRUITING
Trial details
- NCT number
- NCT05384496
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-17
- Primary completion
- 2027-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.